Article
A novel pipeline for the validation of manganese chelators for the treatment of manganese overload
2026-05-15
Abstract excerpt
Manganese neurotoxicity, arising from environmental overexposure or inherited transporter disorders due to pathogenic variants in SLC30A10 and SLC39A14, leads to manganism, a debilitating Parkinsonian movement disorder. Alhtough chelation therapy can partially reverse neuropathology, current clinical practice relies on intravenous CaNa2EDTA, which is burdensome and poorly suited for long-term use. Consequently, th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b603d55d-31c0-5654-a3b3-aebb90a80b06
- DOI
- 10.64898/2026.05.12.724311
